{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T07:04:31Z","timestamp":1696403071469},"reference-count":38,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":725,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Alcohol Clin Exp Res"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1111\/acer.12257","type":"journal-article","created":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T18:35:07Z","timestamp":1378492507000},"page":"511-520","source":"Crossref","is-referenced-by-count":11,"title":["A Phase 2, Placebo-Controlled Study of the Opioid Receptor Antagonist LY2196044 for the Treatment of Alcohol Dependence"],"prefix":"10.1111","volume":"38","author":[{"given":"Conrad J.","family":"Wong","sequence":"first","affiliation":[{"name":"Eli Lilly and Company and\/or one of its wholly owned subsidiaries; Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Witcher","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company and\/or one of its wholly owned subsidiaries; Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Mallinckrodt","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company and\/or one of its wholly owned subsidiaries; Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Dean","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company and\/or one of its wholly owned subsidiaries; Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond F.","family":"Anton","sequence":"additional","affiliation":[{"name":"Medical University of South Carolina; Charleston South Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfei","family":"Chen","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company and\/or one of its wholly owned subsidiaries; Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie A.","family":"Fijal","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company and\/or one of its wholly owned subsidiaries; Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haojun","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company and\/or one of its wholly owned subsidiaries; Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sweta","family":"Dharia","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company and\/or one of its wholly owned subsidiaries; Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott S.","family":"Sundseth","sequence":"additional","affiliation":[{"name":"Cabernet Pharmaceuticals; Chapel Hill North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kory J.","family":"Schuh","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company and\/or one of its wholly owned subsidiaries; Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce J.","family":"Kinon","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company and\/or one of its wholly owned subsidiaries; Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,9,6]]},"reference":[{"key":"10.1111\/acer.12257-BIB0001|acer12257-cit-0001","unstructured":"American Psychiatric Association 2001 Diagnostic and Statistical Manual of Mental Disorders 4th ed American Psychiatric Association Arlington, VA"},{"key":"10.1111\/acer.12257-BIB0002|acer12257-cit-0002","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1021007701808","article-title":"Genotyping of three candidate genes following whole-genome preamplification of DNA collected from buccal cells","volume":"33","author":"Anchordoquy","year":"2003","journal-title":"Behav Genet"},{"key":"10.1111\/acer.12257-BIB0003|acer12257-cit-0003","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1056\/NEJMct0801733","article-title":"Naltrexone for the management of alcohol dependence","volume":"359","author":"Anton","year":"2008a","journal-title":"N Engl J Med"},{"key":"10.1111\/acer.12257-BIB0004|acer12257-cit-0004","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2217\/14622416.9.6.655","article-title":"Genetic basis for predicting response to naltrexone in the treatment of alcohol dependence","volume":"9","author":"Anton","year":"2008b","journal-title":"Pharmacogenomics"},{"key":"10.1111\/acer.12257-BIB0005|acer12257-cit-0005","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/acer.12257-BIB0006|acer12257-cit-0006","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0006-8993(93)90309-B","article-title":"Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats","volume":"621","author":"Benjamin","year":"1993","journal-title":"Brain Res"},{"key":"10.1111\/acer.12257-BIB0007|acer12257-cit-0007","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.physbeh.2004.04.020","article-title":"Is dopamine required for natural reward?","volume":"81","author":"Cannon","year":"2004","journal-title":"Physiol Behav"},{"key":"10.1111\/acer.12257-BIB0008|acer12257-cit-0008","doi-asserted-by":"crossref","first-page":"29557","DOI":"10.1016\/S0021-9258(18)43916-6","article-title":"Mutation of an aspartate residue highly conserved among G-protein-coupled receptors results in non-reciprocal disruption of \u03b12-adrenergic receptor-G-protein interactions","volume":"269","author":"Ceresa","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1111\/acer.12257-BIB0009|acer12257-cit-0009","first-page":"549","article-title":"Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand","volume":"41","author":"Costa","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1111\/acer.12257-BIB0010|acer12257-cit-0010","first-page":"5275","article-title":"Drugs abuse by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Chiara","year":"1988","journal-title":"Neurology"},{"key":"10.1111\/acer.12257-BIB0011|acer12257-cit-0011","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1530-0277.2008.00692.x","article-title":"Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes","volume":"32","author":"Filbey","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/acer.12257-BIB0012|acer12257-cit-0012","first-page":"284","article-title":"Contribution of the opioid system to alcohol aversion and drinking behavior","volume":"287","author":"Froehlich","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/acer.12257-BIB0013|acer12257-cit-0013","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/oxfordjournals.alcalc.a008216","article-title":"Implications of endogenous opioids and dopamine in alcoholism: human and basic science studies","volume":"31","author":"Gianoulakis","year":"1996","journal-title":"Alcohol"},{"key":"10.1111\/acer.12257-BIB0014|acer12257-cit-0014","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.1523\/JNEUROSCI.18-24-10663.1998","article-title":"Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens","volume":"18","author":"Gonzales","year":"1998","journal-title":"J Neurosci"},{"key":"10.1111\/acer.12257-BIB0015|acer12257-cit-0015","doi-asserted-by":"crossref","first-page":"21590","DOI":"10.1016\/S0021-9258(18)45781-X","article-title":"An aspartate conserved among G-protein receptors confers allosteric regulation of \u03b12-adrenergic receptors by sodium","volume":"265","author":"Horstman","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1111\/acer.12257-BIB0016|acer12257-cit-0016","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1037\/0278-6133.21.2.139","article-title":"The DRD4 VNTR polymorphism moderates craving after alcohol consumption","volume":"21","author":"Hutchison","year":"2002","journal-title":"Health Psychol"},{"key":"10.1111\/acer.12257-BIB0017|acer12257-cit-0017","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1038\/sj.npp.1300264","article-title":"Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction","volume":"28","author":"Hutchison","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/acer.12257-BIB0018|acer12257-cit-0018","doi-asserted-by":"crossref","first-page":"23055","DOI":"10.1016\/S0021-9258(19)49424-6","article-title":"A single residue, aspartic acid 95, in the \u03b4 opioid receptor specifies selective high affinity agonist binding","volume":"268","author":"Kong","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1111\/acer.12257-BIB0019|acer12257-cit-0019","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1530-0277.2001.tb02356.x","article-title":"Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis","volume":"25","author":"Kranzler","year":"2001","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/acer.12257-BIB0020|acer12257-cit-0020","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrd897","article-title":"Pharmacotherapy of addictions","volume":"1","author":"Kreek","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1111\/acer.12257-BIB0021|acer12257-cit-0021","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.pbb.2009.03.010","article-title":"The DRD4 exon 3 VNTR polymorphism and addiction-related phenotypes: a review","volume":"93","author":"McGeary","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1111\/acer.12257-BIB0022|acer12257-cit-0022","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1097\/01.ALC.0000099264.36220.48","article-title":"Chronic ethanol consumption by C57BL\/6 mice promotes tolerance to its interoceptive cues and increases extracellular dopamine, an effect blocked by naltrexone","volume":"27","author":"Middaugh","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/acer.12257-BIB0023|acer12257-cit-0023","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0740-5472(95)00021-3","article-title":"What every mental health professional should know about alcohol","volume":"12","author":"Miller","year":"1995","journal-title":"J Subst Abuse Treat"},{"key":"10.1111\/acer.12257-BIB0024|acer12257-cit-0024","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archpsyc.65.4.466","article-title":"Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people","volume":"65","author":"Myrick","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/acer.12257-BIB0025|acer12257-cit-0025","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/sj.npp.1300219","article-title":"A functional polymorphism on the \u03bc-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients","volume":"28","author":"Oslin","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/acer.12257-BIB0026|acer12257-cit-0026","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.physbeh.2004.02.008","article-title":"Opioids and alcoholism","volume":"81","author":"Oswald","year":"2004","journal-title":"Physiol Behav"},{"key":"10.1111\/acer.12257-BIB0027|acer12257-cit-0027","unstructured":"Pettinati HM Weiss RD Miller WR Donovan D Ernst DB Rounsaville BJ 2004 A Clinical Research Guide for Medically Trained Clinicians Providing Pharmacotherapy as Part of the Treatment for Alcohol Dependence. COMBINE Monograph Series, Volume 2. Medical Management Treatment Manual National Institute on Alcohol Abuse and Alcoholism Bethesda, MD"},{"key":"10.1111\/acer.12257-BIB0028|acer12257-cit-0028","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/mp.2010.56","article-title":"A genetic determinant of the striatal dopamine response to alcohol in men","volume":"16","author":"Ramchandani","year":"2011","journal-title":"Mol Psychiatry"},{"key":"10.1111\/acer.12257-BIB0029|acer12257-cit-0029","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1530-0277.2011.01633.x","article-title":"The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review","volume":"36","author":"Ray","year":"2012","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/acer.12257-BIB0030|acer12257-cit-0030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0741-8329(91)90305-G","article-title":"Tests of opioid deficiency hypotheses of alcoholism","volume":"8","author":"Reid","year":"1991","journal-title":"Alcohol"},{"key":"10.1111\/acer.12257-BIB0031|acer12257-cit-0031","first-page":"S5","article-title":"An overview of genetic influences in alcoholism","volume":"36","author":"Schuckit","year":"2009","journal-title":"J Subst Abuse Treat"},{"key":"10.1111\/acer.12257-BIB0032|acer12257-cit-0032","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4612-0357-5_3","volume-title":"Measuring Alcohol Consumption","author":"Sobell","year":"1992"},{"key":"10.1111\/acer.12257-BIB0033|acer12257-cit-0033","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF01535722","article-title":"GSRS-a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease","volume":"33","author":"Svedlund","year":"1988","journal-title":"Dig Dis Sci"},{"key":"10.1111\/acer.12257-BIB0034|acer12257-cit-0034","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1530-0277.2007.00545.x","article-title":"Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment","volume":"32","author":"Tidey","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/acer.12257-BIB0035|acer12257-cit-0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/358149a0","article-title":"Multiple dopamine D4 receptor variants in the human population","volume":"358","author":"Van Tol","year":"1992","journal-title":"Nature"},{"issue":"Suppl 7","key":"10.1111\/acer.12257-BIB0036|acer12257-cit-0036","first-page":"39","article-title":"Naltrexone in the treatment of alcoholism: predicting response to naltrexone","volume":"56","author":"Volpicelli","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/acer.12257-BIB0037|acer12257-cit-0037","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0149-7634(02)00041-6","article-title":"Opioid peptides and the control of human ingestive behavior","volume":"26","author":"Yeomans","year":"2002","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1111\/acer.12257-BIB0038|acer12257-cit-0038","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1111\/j.1471-4159.1985.tb08802.x","article-title":"Differences in binding properties of \u03bc and \u03b4 opioid receptor subtypes from rat brain: kinetic analysis and effects of ions and nucleotides","volume":"44","author":"Zajac","year":"1985","journal-title":"J Neurochem"}],"container-title":["Alcoholism: Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Facer.12257","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/acer.12257\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T18:05:37Z","timestamp":1646503537000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/acer.12257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,6]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"URL":"https:\/\/doi.org\/10.1111\/acer.12257","relation":{},"ISSN":["0145-6008"],"issn-type":[{"value":"0145-6008","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9,6]]}}}